Case Series of Gastric Hepatoid Adenocarcinoma.
10.7704/kjhugr.2015.15.1.53
- Author:
Yu Sik MYUNG
1
;
Jae Pil HAN
;
Su Jin HONG
;
Hye Soo KIM
;
Jung Hwan PARK
;
Hee Kyung KIM
;
Gui Ae JEONG
;
Gyu Seok CHO
Author Information
1. Digestive Disease Center and Research Institute, Department of Internal Medicine, Soonchunhyang University College of Medicine, Bucheon, Korea. rock5014@schmc.ac.kr
- Publication Type:Case Report
- Keywords:
Alpha-fetoproteins;
Stomach neoplasms;
Hepatoid adenocarcinoma;
Prognosis
- MeSH:
Adenocarcinoma*;
alpha-Fetoproteins;
Carcinoma, Hepatocellular;
Humans;
Prognosis;
Stomach;
Stomach Neoplasms;
Survival Rate
- From:The Korean Journal of Helicobacter and Upper Gastrointestinal Research
2015;15(1):53-58
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Hepatoid adenocarcinoma of the stomach (HAS) is a rare form of gastric cancer that histologically resembles hepatocellular carcinoma and is characterized by large amounts of alpha fetoprotein in the serum. The prognosis of HAS is poor compared to that of primary gastric cancer with five-year survival rates of 9% and 44%, respectively. Here, we report five patients diagnosed with HAS. Our experience suggests that an advanced stage of HAS has an extremely poor prognosis, but early detection and radical surgery can help improve the prognosis of the disease.
